Antibiotic Susceptibility Pattern of Aerobic Bacterial Pathogen Isolated from Endotracheal Aspirate

Swetha S1, Pramodhini S2, Umadevi S3

  • 1MBBS Student.

Abstract

Insights

Acinetobacter baumannii is the most common cause of ventilator-associated pneumonia (VAP) in ICUs. High resistance to common antibiotics necessitates careful antibiotic stewardship to combat multidrug-resistant pathogens.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a significant hospital-acquired infection in intensive care units (ICUs).
  • Bacterial resistance is a growing concern in VAP cases.
  • Identifying common pathogens and their antibiotic susceptibility is crucial for effective treatment.

Purpose of the Study:

  • To determine the prevalent bacterial pathogens in endotracheal aspirates from VAP patients.
  • To analyze the antibiotic susceptibility patterns of these isolated pathogens.

Main Methods:

  • A prospective analytical study conducted over one year in a tertiary care hospital.
  • Endotracheal aspirate samples were processed using standard biochemical tests.
  • Antibiotic susceptibility testing was performed using the disk diffusion method following CLSI guidelines.

Main Results:

  • Out of 217 samples, 132 (60.82%) yielded positive bacterial cultures.
  • Acinetobacter baumannii was the most frequent isolate (36.36%), followed by Klebsiella pneumoniae (24.24%) and Pseudomonas aeruginosa (20.45%).
  • High resistance rates were observed for carbapenems, aminoglycosides, and third-generation cephalosporins, with notable sensitivity to piperacillin-tazobactam and cefoperazone-sulbactam.

Conclusions:

  • Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa are key gram-negative pathogens in VAP.
  • The increasing prevalence of multidrug resistance among these pathogens is a major concern.
  • Strict adherence to antibiotic policies and judicious antibiotic use are essential to preserve treatment options for life-threatening infections.